Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.25 -0.12 (-0.9%) Market Cap: 41.58 Bil Enterprise Value: 69.64 Bil PE Ratio: 45.22 PB Ratio: 0.89 GF Score: 68/100

Takeda Pharmaceutical Co Ltd (TAK) Stock Estimates Data

Takeda Pharmaceutical Co Ltd (TAK) 12 Month Price Targets

Takeda Pharmaceutical Co Ltd (TAK) Analyst Rating